Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Tracking How Herpes Simplex Virus Moves Through Cells

November 12, 2015 9:06 am | by Northwestern University | News | Comments

In a recent study, Derek Walsh, PhD, associate professor of Microbiology-Immunology, and his team showed how the herpes simplex virus (HSV) exploits microtubule plus-end tracking proteins to initiate transport and infection in human cells. Read more...


Taking Care on Painkillers for Kids

November 12, 2015 9:01 am | News | Comments

The U.S. Food and Drug Administration in August approved the opioid painkiller OxyContin for use in children as young as 11, sparking a national outcry prompted by addiction concerns. Read more...


6 Steps Towards Clinical Evaluation Report (CER) Compliance

November 12, 2015 8:53 am | by Chris Rule, Manager, Solutions Delivery at Maetrics | Articles | Comments

Following scandals such as Poly Implant Prostheses’ (PIP) use of cheaper, industrial-grade silicone in breast implants and toxic debris from metal-on-metal (MoM) hip implants, Clinical Evaluation Reports (CERs) have become an increasingly hot topic in the Medical Device regulatory world. Now thrust into the public eye, Notified Bodies (NBs) are increasingly scrutinising CERs in order to protect Patient Safety. Read more...


Mylan Launches Generic Fusilev for Injection

November 12, 2015 8:15 am | News | Comments

Its the generic version of Spectrum Pharmaceuticals' Fusilev for Injection. Read more...


Ebola Remains in Guinea, Where the Outbreak Began

November 12, 2015 8:00 am | by Boubacar Diallo and Yousouff Bah, Associated Press | News | Comments

After killing more than 11,000 people, West Africa's Ebola outbreak is down to a handful of cases. Read more...


Roche Gets FDA Approval for New Advanced Melanoma Treatment

November 12, 2015 7:45 am | News | Comments

Today’s FDA approval is based on results from the Phase 3 coBRIM study. Read more...


Global Health Team Pioneers Development of New Antimalarial Drug Screening Model

November 12, 2015 7:30 am | by University of South Florida | News | Comments

The malaria parasite is becoming increasingly resistant to the drug artemisinin as the front-line treatment to combat the mosquito-borne disease. Read more...


World First Blood Cancer Drug Trial Reveals Life-Changing Results

November 12, 2015 7:15 am | by University of Leicester | News | Comments

The success story of this drug, has paved the way for its future development in combination studies, which will be opening to recruitment shortly in Leicester. Read more...


Canadian Researchers Improve Safety, Decreases Risk of New Blood Thinners

November 12, 2015 7:00 am | by McMaster University | News | Comments

Blood thinners are used to prevent and treat blood clots in a number of conditions including atrial fibrillation. Read more...


Novartis Heart Failure Medicine Entresto Cuts 30-day Hospital Readmissions, Analysis Shows

November 11, 2015 10:23 am | News | Comments

Novartis announced today data from a new analysis demonstrating that fewer heart failure patients with reduced ejection fraction (HFrEF) treated with Entresto (sacubitril/valsartan) tablets were readmitted to the hospital for heart failure or for any cause within 30 days of discharge from a heart failure hospitalization compared to patients treated with enalapril.  Read more...


Boehringer Ingelheim: Completed Enrollment of Phase 3 Trial for Biosimilar Candidate to Adalimumab

November 11, 2015 10:17 am | News | Comments

Boehringer Ingelheim today announced it has completed enrollment for the pivotal Phase 3 trial (NCT02137226) of BI695501, a biosimilar candidate to adalimumab (AbbVie's Humira). Read more...


Rare Her2 Mutations May Not Always Spur Breast Cancer on Their Own

November 11, 2015 10:08 am | by Johns Hopkins University | News | Comments

Results of a new laboratory study by Johns Hopkins Kimmel Cancer Center researchers suggests that some rare "missense" mutations in the HER2 gene are apparently not — on their own — capable of causing breast cancer growth or spread. Read more...


Nobelist Calls Macular Degeneration Trials “One of Most Successful” in Stem Cell Field

November 11, 2015 10:04 am | by Cynthia Fox, Science Editor | Articles | Comments

Clinical trials for what Nobel Prize-winner Sir John Gurdon, D.Phil., recently called “one of the most successful stem cell treatments so far” are cranking into second gear. Read more...


On Top of the Flu

November 11, 2015 10:01 am | by Harvard University | News | Comments

Harvard statisticians have devised a new method to track the flu via Internet search data, potentially providing public health officials and consumers alike with advance warning this flu season. Read more...


Express Scripts Sues Horizon, Fight Over Prescriptions Grows

November 11, 2015 9:48 am | by Tom Murphy, AP Business Writer | News | Comments

The drugmaker Horizon Pharma is questioning its relationship with an Express Scripts business after the pharmacy benefits giant sued Horizon for about $140 million and dumped a pharmacy that dispenses its drugs. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.